Recurrent mutation of the gene encoding sequestosome 1 (SQSTM1/p62) in Paget disease of bone.
Open accessThe DOI matches its Crossref record; 45 of the 47 references it cites were found in a registry or an index.
Abstract
Paget disease of bone (PDB) is a common disorder characterized by focal and disorganized increases of bone turnover. Genetic factors are important in the pathogenesis of PDB. We and others recently mapped the third locus associated with the disorder, PDB3, at 5q35-qter. In the present study, by use of 24 French Canadian families and 112 unrelated subjects with PDB, the PDB3 locus was confined to approximately 300 kb. Within this interval, two disease-related haplotype signatures were observed in 11 families and 18 unrelated patients. This region encoded the ubiquitin-binding protein sequestosome 1 (SQSTM1/p62), which is a candidate gene for PDB because of its association with the NF-kappaB pathway. Screening SQSTM1/p62 for mutations led to the identification of a recurrent nonconservative change (P392L) flanking the ubiquitin-associated domain (UBA) (position 394-440) of the protein that was not present in 291 control individuals. Our data demonstrate that two independent mutational events at the same position in SQSTM1/p62 caused PDB in a high proportion of French Canadian patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Most recently, mutations in the sequestosome 1 gene, a scaffold protein in the NF-B signaling pathway, have been demonstrated in some cases of familial and sporadic PDB (399 -404).”
From Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease (2008) · cites this paper as [403]
In the citing paper
“SQSTM1 mutations are not only a rare cause of ALS-FTD, accounting for ~1-3.5% of cases with or without family history [123–125], but also Paget’s disease of bone (PDB), a chronic and progressive skeletal disorder characterized by disorganized bone turnover [126,127], and inclusion body myositis (IBM) [128].”
From Autophagy and ALS: mechanistic insights and therapeutic implications (2022) · cites this paper as [126]
Citations
Cites
SMART, a simple modular architecture research tool: Identification of signaling domains
Schultz, J., Milpetz, F., Bork, P., & Ponting, C. P. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.5857 · Cited by 3,599 · cited 4×
“Cosegregation of the P392L variant with the phenotype, its absence in 86 spouses and 205 individuals from the general population, the nonconservative nature of the amino acid substitution, and the conservation of the UBA domain, including the P392 residue, among other species (mouse and rat) provided support for the i…”
BackgroundInfluentialA comprehensive genetic map of the human genome based on 5,264 microsatellites
Dib, C., Fauré, S., Fizames, C., Samson, D., Drouot, N., Vignal, A., Millasseau, P., Marc, S., Kazan, J., Seboun, E., et al. (1996) · Nature · doi:10.1038/380152a0 · Cited by 2,928 · cited 1×
“markers (Dib et al. 1996), present within this interval, using an ePCR approach (Schuler 1998).”
MethodSelf-citationHsu, H., Lacey, D. L., Dunstan, C. R., Solovyev, I., Colombero, A., Timms, E., Tan, H.-L., Elliott, G., Kelley, M. J., Sarosi, I., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.3540 · Cited by 1,636 · cited 1×
“Osteoclast formation and activation involve the receptor activator of NF-kB (RANK) pathway, a tumor-necrosis factor (TNF) family member (Hsu et al. 1999).”
BackgroundThe staden sequence analysis package
Staden, R. (1996) · Molecular Biotechnology · doi:10.1007/bf02900361 · Cited by 1,263 · cited 1×
“Both strands were analyzed using STADEN package 1.1 (Staden 1996).”
MethodInfluentialSobel, E. M., & Lange, K. L. (1996) · PubMed Central · Cited by 1,176
Principles and Practice of Endocrinology and Metabolism.
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-9-816_4 · Cited by 803
Naito, A., Azuma, S., Tanaka, S., Miyazaki, T., Takaki, S., Takatsu, K., Nakao, K., Nakamura, K., Katsuki, M., Yamamoto, T., et al. (1999) · Genes to Cells · doi:10.1046/j.1365-2443.1999.00265.x · Cited by 635 · cited 6×
“1999), and TRAF6-deficient mice exhibit severe osteopetrosis and are defective in osteoclast formation because of impaired signaling induced by RANK (Naito et al. 1999).”
BackgroundInfluentialMutations in TNFRSF11A, affecting the signal peptide of RANK, cause familial expansile osteolysis
Hughes, A. E., Ralston, S. H., Marken, J., Bell, C., MacPherson, H., Wallace, R. G. H., van Hul, W., Whyte, M. P., Nakatsuka, K., Hovy, L., et al. (2000) · Nature Genetics · doi:10.1038/71667 · Cited by 481 · cited 1×
“Activating mutations of the TNFRSF11A gene encoding this receptor have been found to be responsible for FEO and rare cases of early-onset familial PDB (Hughes et al. 2000).”
BackgroundThe atypical PKC-interacting protein p62 channels NF-kappa B activation by the IL-1-TRAF6 pathway
Sanz, L. (2000) · The EMBO Journal · doi:10.1093/emboj/19.7.1576 · Cited by 436 · cited 7×
“The functional importance of SQSTM1/p62 in NF-kB activation has been further highlighted by the observation that its depletion severely abrogated NF-kB activation through the TNFa or IL-1 pathways (Sanz et al. 1999, 2000).”
BackgroundInfluentialThe interaction of p62 with RIP links the atypical PKCs to NF-kappa B activation
Sanz, L. (1999) · The EMBO Journal · doi:10.1093/emboj/18.11.3044 · Cited by 410 · cited 7×
“The functional importance of SQSTM1/p62 in NF-kB activation has been further highlighted by the observation that its depletion severely abrogated NF-kB activation through the TNFa or IL-1 pathways (Sanz et al. 1999, 2000).”
BackgroundInfluential
Research works printed but not linked: 1
- Glaser, 1999, Intragenic single nucleotide polymorphism haplotype analysis of SUR1 mutations in familial hyperinsulinism, Hum Mutat, 14, 23, 10.1002/(SICI)1098-1004(1999)14:1<23::AID-HUMU3>3.0.CO;2-# · doi:10.1002/(sici)1098-1004(1999)14:1<23::aid-humu3>3.0.co;2-#
Cited by
Items 501–563 of 563
Genetic Basis of Orthopedic Diseases
Nuran, R., Başçı, O., & Karahan, M. (2015) · Springer eBooks · doi:10.1007/978-3-319-20777-3_14
Analyse moléculaire de la maladie osseuse de Paget
Michou, L., Collet, C., & Orcel, P. (2006) · Pathologie Biologie · doi:10.1016/j.patbio.2006.06.005
Clinical Investigations SQSTM1 and Paget's Disease of Bone
Layfield, R., & Hocking, L. J. (2004)
Developmental Aspects of Pagetic Osteoclasts
Galson, D. L., Sun, Q., & Roodman, G. D. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-805083-5.00004-x
Genetische Skeletterkrankungen und Entwicklungsstörungen
Werner, M. (2015) · Springer eBooks · doi:10.1007/978-3-642-04566-0_42
Novel genetic defects in titinopathies and other muscular dystrophies
Evilä, A. (2016) · Helda - University of Helsinki Institutional Repository
Visions & Reflections Etiologic factors in Paget's disease of bone
Reddy, S. V. (2006)
Multilokulärer Morbus Paget bei IBMPFD-Syndrom: Darstellung eines Krankheitsverlaufes über 14 Jahre
Zajonz, D., Langsieb, C., Chavdarova, L., Kellermann, S., Baum, P., Wickenhauser, C., von Salis-Soglio, G., & Prietzel, T. (2012) · Der Orthopäde · doi:10.1007/s00132-012-1935-6
GENETIC FACTORS ASSOCIATED WITH AMYOTROPHIC LATERAL SCLEROSIS
Vrabec, K., & Ravnik‐Glavač, M. (2015) · DOAJ (DOAJ: Directory of Open Access Journals)
ROLES OF TMIGD3 AND A3AR IN SUPPRESSION OF OSTEOSARCOMA MALIGNANCY
Iyer, S. V. (2016) · KU ScholarWorks (The University of Kansas)
Functional characterisation of an osteoclast-derived osteoblastic factor (ODOF)
Phan, T. A. (2004) · UWA Profiles and Research Repository (UWA) · Cited by 2
Audet, M.-C., Jean, S., Beaudoin, C., Guay-Bélanger, S., Dumont, J., Brown, J. P., & Michou, L. (2017) · Revue du Rhumatisme · doi:10.1016/j.rhum.2017.09.006
Self-citationKurihara, N., & Roodman, G. D. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-809963-6.00085-7
Ku, J. A., Gidley, P. W., & Sturgis, E. M. (2018) · Springer eBooks · doi:10.1007/978-3-319-74539-8_13
A case of axial spondyloarthritis with paget"s disease: a rare coexistence
Tekgöz, E., Çınar, M., Sanal, H. T., & Yılmaz, S. (2019) · Gulhane Medical Journal · doi:10.26657/gulhane.00061
Roodman, G. D. (2004) · BMC News and views · doi:10.1186/2048-4623-4-s2-op010
Seton, M. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-09138-1.00206-0
Johnson, M. L. (2007) · Elsevier eBooks · doi:10.1016/b978-008055232-3.60684-1
Sreedharan, J., & Brown, R. H. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-410529-4.00087-5
Greenspan, A., & Beltran, J. (2017) · Elsevier eBooks · doi:10.1016/b978-3-437-23064-6.00029-0
Giusti, F., D’Asta, F., Marini, F., & Brandi, M. L. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-386456-7.03105-1
Grauer, A., Siris, E. S., & Ralston, S. H. (2006) · Elsevier eBooks · doi:10.1016/b9-78-012088-5/62650-0480
The investigation and management of common polyostotic bone conditions
Scotcher, M., Eastley, N. C., & Ashford, R. U. (2021) · Orthopaedics and Trauma · doi:10.1016/j.mporth.2021.03.003
Clinical Heterogeneity of ALS – Implications for Models and Therapeutic Development
Lattante, S., & Sabatelli, M. (2021) · Wiley eBooks · doi:10.1002/9781119745532.ch1
Morbus Paget des Knochens – eine aktuelle Übersicht zu Klinik, Diagnostik und Therapie
Klemm, P., Dischereit, G., von Gerlach, S., & Lange, U. (2021) · Journal für Mineralstoffwechsel & Muskuloskelettale Erkrankungen · doi:10.1007/s41970-021-00158-6
Experiencias educativas en el Parque Nacional de Doñana
España, M. C. C., Ortiz, E. M. L., & Giner, M. I. C. (1997) · Deposito de Investigacion Universidad de Sevilla (University of Seville)
Treatment of Paget's disease of the bone: long-term effect of neridronate in a real-life setting
ROMANO, F., BENEDETTO, E. D., SCARANO, E., RICCIO, E., ARIANNA, R., COLAO, A., & Somma, C. D. (2022) · Minerva Endocrinology · doi:10.23736/s2724-6507.20.03320-9
Hereditary Disorders of the Skeleton
Whyte, M. P. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5583-9.00067-8
Ralston, S. H. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.95769-6
Singer, F. R. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5583-9.00071-x
Niedhart, C. (2010) · Springer eBooks · doi:10.1007/978-3-642-05385-6_9
Reid, I. R. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.735158194.793563670
Seton, M. (2011) · Elsevier eBooks · doi:10.1016/b978-0-323-06551-1.00202-5 · Cited by 2
Moscat, J., & Díaz-Meco, M. T. (2006) · AfCS-Nature Molecule Pages · doi:10.1038/mp.a003917.01
Dionisi‐Vici, C., Jungbluth, H., Carsetti, R., & van Karnebeek, C. (2022) · Springer eBooks · doi:10.1007/978-3-030-67727-5_59
Reid, I. R., & Seton, M. (2023) · Springer eBooks · doi:10.1007/978-3-031-23488-0_42
Kurihara, N., & Roodman, G. D. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-91338-6.00032-x
A Comprehensive Guide to Paget’s Disease of Bone
Chintakayala, S. K., Ravipati, A., Mugada, V. K., & Yarguntla, S. R. (2023) · Research Journal of Pharmacology and Pharmacodynamics · doi:10.52711/2321-5836.2023.00033
Phillips, J., Subedi, D., Lewis, S. C., Keerie, C., & Ralston, S. H. (2024) · Efficacy and Mechanism Evaluation · doi:10.3310/ftkc2007 · Cited by 1
Paget’s Disease of Bone: Evaluation and Advances in Management
Merlotti, D., & Gennari, L. (2023) · Endocrinology · doi:10.1007/978-3-030-19632-5_11-1
Paradas, C., Carbonell, P., Llansó, L., & Olivé, M. (2025) · Elsevier eBooks · doi:10.1016/b978-0-323-95702-1.00435-8
Atypical Ocular Myasthenia-Like Presentation in a Patient With a Heterozygous SQSTM1 Variant
Sanchez-Cordero, M., Rosado, J. M., Troia, F. R., & Villa, F. J. O. (2025) · Cureus · doi:10.7759/cureus.87371
“Studies have shown that SQSTM1 mutations can result in complex neurological presentations, ranging from ALS and FTD to myopathy and sensorimotor neuropathy, expanding the gene's phenotypic range [6,9,14].”
Clinical phenotype of frontotemporal dementia associated with the Pro392Leu SQSTM1 mutation
Escobar, J. R., Agüero, P., Martínez-Ulloa, P., Sainz, M. J., Pérez‐Pérez, J., & Gómez‐Tortosa, E. (2025) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2025.2549308 · Cited by 1
Case Report: Treatment response of SQSTM1–ALK fusion lung adenocarcinoma to multiple ALK inhibitors
Gu, J., Zhang, J., Li, S., Lin, Z., Huang, L., & Zhou, Y. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1608080 · Cited by 1
Atypical Frontotemporal Dementia Associated With SQSTM1 Gene Mutation: A Clinicopathological Case
Espinoza‐Vinces, C., Zelaya, M. V., Pueyo, V. C., Montoya‐Murillo, G., Patiño‐García, A., Villino‐Rodríguez, R. A., Atorrasagasti-Villar, A., Arbizu, J., & Riverol, M. (2025) · Neuropathology · doi:10.1111/neup.70029
Epermane, M., Eņǵele, I., & Jaunozola, D. (2023) · Springer eBooks · doi:10.1007/978-3-030-57376-8_79-1
Gennari, L., Merlotti, D., Paola, V. D., Calabrò, A., Martini, G., Avanzati, A., & Nuti, R. (2009) · Springer eBooks · doi:10.1007/978-88-470-1357-5_23
Ralston, S. H. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00082-0
Langston, A. L., Johnston, M., Robertson, C., Campbell, M. K., Entwistle, V. A., Marteau, T. M., McCallum, M., & Ralston, S. H. (2021) · Figshare · doi:10.6084/m9.figshare.15064558
Langston, A. L., Johnston, M., Robertson, C., Campbell, M. K., Entwistle, V. A., Marteau, T. M., McCallum, M., & Ralston, S. H. (2021) · Figshare · doi:10.6084/m9.figshare.15064561
Conditional truncation of the FUS protein in mice : a new animal model of the ALS/FTD continuum
Scekic‐Zahirovic, J. (2016) · theses.fr (ABES) · doi:10.70675/6bed4f95z0a05z438fz937ez33f29f11923d
Coulon, P.-G. A. (2014) · theses.fr (ABES) · doi:10.70675/35505ce2z6226z4be3z9fc3za30de5ecacdc
Implication de la DYMECLINE et de GRASP65 dans les golgipathies neurodéveloppementales
Lebon, S. (2024) · theses.fr (ABES) · doi:10.70675/db1a0242zb212z4e35z90e7z352682b2ac10
Paget’s disease of bone in a non-endemic region: A case report
Mirghorbani, S. M., Shakeri, A., Rashvand, H., Soleimani, A. M., & Shamsi, S. (2026) · Nyādarśa paṃjīkaraṇa buleṭina · doi:10.66224/rr.2026.11.2.49
Yadav, A., ., P., & Kumar, S. (2026) · International Journal of Science and Healthcare Research · doi:10.52403/ijshr.20260333
Paget Disease of the Calvarium: A Case Report
Navabi, K., & Patel, E. (2026) · Cureus · doi:10.7759/cureus.116917
“Mutations in SQSTM1 have been identified in 40-50% of familial cases and 5-10% of sporadic cases [7].”
Epermane, M., Eņǵele, I., & Jaunozola, D. (2026) · Springer eBooks · doi:10.1007/978-3-031-66892-0_79
Gudino, L. C., Nájera, C. R., Gómez, I. M. D., & López, L. D. (2026) · Revista de Osteoporosis y Metabolismo Mineral · doi:10.20960/revosteoporosmetabminer.00133
Yavuz, D. G., Salva, H., Ata, P., Arslan, E. O., Hanoğlu, O., Azimi, M., Hekimsoy, Z., Doğruel, H., Sarı, R., Öztürk, F. Y., et al. (2026) · Bone · doi:10.1016/j.bone.2026.118134
The Dual Role of HIF Hydroxylase PHD3 in Cancer Cell Survival
Rantanen, K. (2012) · UTUPub (University of Turku)
Metadata
- Authors
- Laurin, N., Brown, J. P., Morissette, J., & Raymond, V.
- Affiliations
- Centre hospitalier de l'Université Laval (CA)
- Corresponding author
- Raymond, Vincent
- ORCID
- Brown, Jacques P.
- Venue
- The American Journal of Human Genetics
- Publisher
- Elsevier BV
- Published
- 2002-06
- Volume
- 70
- Issue
- 6
- Pages
- 1582-1588
- ISSN
- 0002-9297 (ISSN-L)
- PMC
- PMC379146
- OpenAlex
- W2011308707
- Cited by
- 563
- References
- 47
- Citations by year
- 2026: 9 · 2025: 14 · 2024: 10 · 2023: 23 · 2022: 14 · 2021: 19 · 2020: 26 · 2019: 25 · 2018: 19 · 2017: 14 · 2016: 34 · 2015: 28 · 2014: 35 · 2013: 30 · 2012: 31
- FWCI
- 7.78
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 4066 d)
- Locations
- The American Journal of Human Genetics (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Fonds pour la Formation de Chercheurs et l'Aide à la Recherche
- Canadian Institutes of Health Research (MOP-3804)
- Fonds de Recherche du Québec - Santé
- Canada Foundation for Innovation (548)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Alkaline Phosphatase Research Studies
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone Tumor Diagnosis and Treatments
- Keywords
- Paget's disease of bone, p62, recurrent mutations, ubiquitin-associated domain, haplotype mapping, French-Canadian families, NF-κB signaling, genetic susceptibility, bone turnover
- MeSH terms
- Sequestosome-1 Protein, Base Sequence, Canada, Carrier Proteins, France, Genetic Testing, Haplotypes, Heterozygote, Homozygote, Humans, Molecular Sequence Data, Mutation, Osteitis Deformans, Proteins, Adaptor Proteins, Signal Transducing
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.